Blog
Fruquintinib significantly extends survival in refractory metastatic colorectal cancer
July 2023 Fruquintinib is a small molecule inhibitor of the vascular endothelial growth factor receptors(VEGFs). VEGFs are involved in the...
Chemotherapy sequence in advanced colorectal cancer
July 2023 Phase III studies have shown the advantage of combining chemotherapy agents fluorouracil (5-FU) with folinic acid (leucovorin) and...
Patient-reported outcomes from the PROSPECT trial: treatment for locally advanced rectal cancer
A recent analysis from the PROSPECT trial examined trends in patient-reported outcomes among those who received neoadjuvant FOLFOX (fluorouracil, leucovorin,...
Trastuzumab deruxtecan shows activity in HER2+ metastatic colorectal cancer
The DESTINY-CRC01 trial was one of the first studies to show that the targeted therapy trastuzumab deruxtecan (T-DXd) was able...
Stress Management: What stress does to your body and how to reduce it.
Some forms of stress are not harmful to our body such as the stress we feel before an exam or...
Combination of patient, provider outreach boosts CRC screening in high-risk individuals
May 2023 Recent data presented at Digestive Disease Week in Chicago, IL showed that a multicomponent strategy, including outreach to...
